Aymanshafei (Talk | contribs) |
Aymanshafei (Talk | contribs) |
||
Line 12: | Line 12: | ||
<style> | <style> | ||
.PARTS {border: 1px solid #fff; | .PARTS {border: 1px solid #fff; | ||
− | background: rgba(255,255,255, 0.3) | + | background: rgba(255,255,255, 0.3) !important} |
table { | table { | ||
font-family: arial, sans-serif; | font-family: arial, sans-serif; |
Latest revision as of 19:57, 26 October 2017
Part Name | Description | Length | Link |
---|---|---|---|
BBa_K2217019 | Cas9 Knock-in | 6035 | HERE |
BBa_K2217020 | BBa_K2217001 ceRNA hsa-circ-0000064 | 867 | HERE |
BBa_K2217022 | laci + miRNA-1825 binding site on hsa-circ-0000064 Production | 1732d | HERE |
Fragments
These composite parts were synthesised as separate gene fragments then assembled to form BBa_K2217025 and BBa_K2217026 representing ceRNA and CRISPR circuits respectively.
Part Name | Description | Length | Link |
---|---|---|---|
BBa_K2217024 | CMV Enhancer + CMV Promoter + T7 | 542 | HERE |
BBa_K2217027 | laci + miRNA-1825 binding site synthesized fragment | 1210 | HERE |
BBa_K2217028 | BBa_K2217001 ceRNA hsa-circ-0000064 + sv_poly(A) Synthesized Fragment | 269 | HERE |
BBa_K2217013 | CAG Promoter | 590 | HERE |
BBa_K2217023 | YFP for ceRNA circuit characterization | 1015 | HERE |
BBa_K2217018 | gRNA for Cas9 Knock-in | 483 | HERE |
BBa_K2217029 | CMV Enhancer + CMV Promoter | 516 | HERE |